News

August 6, 2019

Phase 1 Trial of Betalutin, a Radioimmunotherapy, in Advanced DLBCL Now Fully Enrolled

News

The Phase 1 trial evaluating Betalutin — an investigational tumor-targeting antibody labeled with a type of radiation — in people with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) is now fully ... Read more

August 2, 2019August 2, 2019

First Patient Dosed in Trial Testing Abexinostat-Imbruvica Combo for Advanced Lymphomas

News

Xynomic Pharma has initiated patient dosing in a Phase 1/2 trial testing its investigational therapy abexinostat, in combination with Imbruvica (ibrutinib), as a treatment for people with mantle cell lymphoma (MCL) and ... Read more

August 1, 2019

Allergan Issues Worldwide Recall of Some Breast Implant Products Due to Lymphoma Risk

News

Allergan has issued a worldwide recall of its BIOCELL textured breast implant products, due to the potential risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). The recall — for Allergan’s proprietary ... Read more

July 30, 2019August 26, 2019

FDA Approves Rituxan Biosimilar Ruxience for Non-Hodgkin’s Lymphoma

News

The U.S. Food and Drug Administration (FDA) has approved Pfizer’s Ruxience (rituximab-pvvr), a biosimilar to Rituxan (rituximab), for all non-Hodgkin’s lymphoma indications of its reference product, the company announced. The therapy ... Read more

July 26, 2019

$169K Raised by Local California Chapter in Annual Campaign of the Leukemia & Lymphoma Society

News

Nearly $169,000 was raised to support the Leukemia & Lymphoma Society’s research, legislative advocacy, and patient support efforts by one of its chapter’s Man & Woman of the Year campaign. ... Read more

July 25, 2019

Triumvira Cleared to Begin Clinical Testing of TAC01-CD19 in B-cell Lymphomas

News

Triumvira Immunulogics is launching a Phase 1/2 clinical trial to test its T-cell therapy candidate, TAC01-CD19, in patients with B-cell lymphoma across the U.S. and Canada, the company announced. The ... Read more

July 23, 2019

NantKwest Launches Phase 1 Trial to Assess Investigational Cell Therapy for B-cell Lymphomas

News

NantKwest is launching the first-in-human Phase 1 clinical trial assessing the effects of its investigational CD19 t-haNK cell therapy in people with locally advanced B-cell lymphoma. The trial follows the ... Read more

July 19, 2019July 19, 2019

Affimed Trial Updates Support AFM13 Use for Certain CD30-positive Lymphomas

News

Updated results from two clinical trials support the potential of AFM13, an investigational immunotherapy being developed by Affimed, in combination with Merck‘s Keytruda (pembrolizumab) for patients with Hodgkin’s lymphoma, or ... Read more

July 18, 2019

Localized and Superficial Brain PCNS Lymphomas May Benefit from Surgery, Study Reviews Suggest

News

Certain patients with primary central nervous system (PCNS) lymphoma, a rare type of brain cancer, may benefit more from having surgery to remove their tumor than following the current standard ... Read more

July 16, 2019

FDA Grants Fast Track Status to Investigational Compound CLR 131 for DLBCL

News

Cellectar Biosciences’ investigational radiotherapeutic compound, CLR 131, has received fast track designation by the U.S. Food and Drug Administration (FDA) for the treatment of relapsed or refractory diffuse large B-cell ... Read more